Maurizio Fava is the executive vice chair of the Department of Psychiatry and executive director of the Clinical Trials Network and Institute at Massachusetts General Hospital (MGH), and an associate member of the Broad Institute’s Stanley Center for Psychiatric Research. He is also the director of the Depression Clinical and Research Program (DCRP) at MGH and the Slater Family Professor of Psychiatry at Harvard Medical School.
Fava is a world leader in the field of depression. Under his direction, MGH’s Depression Clinical and Research Program has become one of the most highly regarded depression programs in the country, conducting research in a variety of areas, including pharmacotherapy of resistant depression, neuroimaging, genetics, neurophysiology, neuroendocrinology, novel pharmacotherapies, alternative medicine, and psychotherapy. He has also mentored more than 50 trainees who have gone on to become lead investigators in the area of depression.
Fava’s research has been mainly focused on the development of effective short-term and long-term strategies in the treatment of depression and depressive subtypes, and the study of treatment-resistant depression. He also served as the co-principal investigator of STAR*D, the largest research study ever conducted in the area of depression, and of the RAPID Network, a series of studies of novel, rapidly-acting antidepressant therapies funded by the National Institute of Mental Health. At the Broad, he will be consulting with the Stanley Center’s leadership on the development of proof-of-concept clinical trials.
During his career, he has received several awards, including the Ethel Dupont-Warren Fellowship in Psychiatry at Harvard Medical School. He is the current president of the American Society of Clinical Psychopharmacology and is on the editorial board of five international medical journals, including the Annals of Clinical Psychiatry and the Journal of Clinical Psychiatry.
Fava received his M.D. and completed his residency training in endocrinology at the University of Padova School of Medicine, Italy. He then completed his residency training in psychiatry at MGH.